Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Novo Nordisk Inc. et al v. Paddock Laboratories, Inc.
Case Number:
0:10-cv-02199
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 11, 2011
Novo Seeks To Toss Antitrust Claims in Prandin Suit
Pharmaceutical company Novo Nordisk Inc. has asked a judge to toss antitrust claims made by generic-drug maker Paddock Laboratories Inc. in an infringement dispute over Novo's diabetes drug Prandin, saying it is not to blame for Paddock's delayed market entry.
-
December 01, 2010
Novo Patent Fight Over Prandin To Stay In Minn.
The federal judge overseeing Novo Nordisk Inc.'s patent infringement suit against Paddock Laboratories Inc. over diabetes drug Prandin has determined that the U.S. District Court for the District of Minnesota has priority to hear the parties' dispute over whether Novo has unlawfully monopolized the market for the drug.